306 generics · 531 brands
The Ibn Sina Pharmaceutical Industry PLC is a well-established pharmaceutical company in Bangladesh, recognized for its contribution to the country’s healthcare sector. Established in 1983, the company operates as part of the Ibn Sina Group and has developed a strong reputation for manufacturing quality medicines and healthcare products. Headquartered in Dhaka, Bangladesh, the company serves the domestic pharmaceutical market through its extensive product range and distribution network. Its focus on quality, innovation, and affordable healthcare has helped it become a recognized name among pharmaceutical manufacturers in Bangladesh.
The Ibn Sina Pharmaceutical Industry PLC manufactures a wide variety of pharmaceutical products, including tablets, capsules, injections, syrups, suspensions, and other specialized formulations. Its product portfolio covers several therapeutic areas, such as cardiovascular diseases, diabetes, gastrointestinal disorders, respiratory conditions, infections, and neurological disorders. The company also produces different healthcare formulations to address various treatment requirements. Its diverse range of medicines supports healthcare professionals and patients across multiple medical fields.
The company emphasizes modern manufacturing technology, quality control, research, and continuous product development to maintain its pharmaceutical standards. It aims to provide effective and accessible medicines while meeting established manufacturing requirements. Through its nationwide distribution network and export activities, The Ibn Sina Pharmaceutical Industry PLC continues to strengthen its presence in the pharmaceutical market. With decades of experience and a commitment to healthcare development, the company remains an important contributor to Bangladesh’s pharmaceutical industry.